| MolName | [2-(2-chloro-5-morpholin-4-ylsulfonylanilino)-2-oxoethyl] (E)-3-[3-(4-chlorophenyl)-1-phenylpyrazol-4-yl]prop-2-enoate |
| MolecularFormula | C30H26N4O6Cl2S |
| Smiles | O=C(COC(/C=C/c1cn(-c2ccccc2)nc1-c(cc1)ccc1Cl)=O)Nc(cc(cc1)S(N2CCOCC2)(=O)=O)c1Cl |
| InChI | InChI=1S/C30H26Cl2N4O6S/c31-23-9-6-21(7-10-23)30-22(19-36(34-30)24-4-2-1-3-5-24)8-13-29(38)42-20-28(37)33-27-18-25(11-12-26(27)32)43(39,40)35-14-16-41-17-15-35/h1-13,18-19H,14-17,20H2,(H,33,37) |
| InChIK | VLHAGUXIUYUHMU-UHFFFAOYSA-N |
| TotalMolweight | 641.53 |
| Molweight | 641.53 |
| MonoisotopicMass | 640.09501 |
| CLogP | 3.868 |
| CLogS | -5.592 |
| H Acceptors | 10 |
| H Donors | 1 |
| TotalSurfaceArea | 458.98 |
| Relative PSA | 0.23424 |
| PolarSurfaceArea | 128.21 |
| Druglikeness | 5.3407 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | high |
| Nasty Functions | |
| Shape Index | 0.51163 |
| Fragments | 1 |
| Non HAtoms | 43 |
| NonCHAtoms | 13 |
| Electronegative Atoms | 13 |
| Rotatable Bond | 9 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 4 |
| Aromatic Atoms | 23 |
| Sp3Atoms | 8 |
| Symmetricatoms | 7 |
| Amides | 2 |
| Aromatic Nitrogens | 2 |
| StereoCon |
Click to Load Molecule:
1 - [2-(2-chloro-5-morpholin-4-ylsulfonylanilino)-2-oxoethyl] (E)-3-[3-(4-chlorophenyl)-1-phenylpyrazol-4-yl]prop-2-enoate | 2 - [2-(2-chloro-5-morpholin-4-ylsulfonylanilino)-2-oxoethyl] (E)-3-[3-(4-chlorophenyl)-1-phenylpyrazol-4-yl]prop-2-enoate